title: Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both?
authors.forename: G
authors.initials: G
authors.lastname: Therapondos
authors.forename: J N
authors.initials: JN
authors.lastname: Plevris
authors.forename: M M
authors.initials: MM
authors.lastname: Dollinger
authors.forename: P C
authors.initials: PC
authors.lastname: Hayes
authors.forename: A D
authors.initials: AD
authors.lastname: Flapan
mesh_terms: D006332:Cardiomegaly / Q000139:chemically induced*; D016572:Cyclosporine / Q000009:adverse effects*; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016031:Liver Transplantation; D016559:Tacrolimus / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus